Evidence map›Paper›PMID 41181603›Full record

ReviewFrontiers in pharmacology2025

Application and research progress on artificial intelligence in the quality of Traditional Chinese Medicine.

Mei-Yu Li, Jun-Qing Zhu, Xiao-Nan Liu, Meng-Yue Wu, Kun Dong, Xiao-Yan Li, Peng Gao, Zhi-Hui Jiang

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mei-Yu LiShandong Key Laboratory of Digital Traditional Chinese Medicine, Institute of Pharmacy (Institute of TCM Health Industrial Technology), Shandong University of Traditional Chinese Medicine, Jinan, China.
Jun-Qing ZhuShandong Key Laboratory of Digital Traditional Chinese Medicine, Institute of Pharmacy (Institute of TCM Health Industrial Technology), Shandong University of Traditional Chinese Medicine, Jinan, China.
Xiao-Nan LiuShandong Key Laboratory of Digital Traditional Chinese Medicine, Institute of Pharmacy (Institute of TCM Health Industrial Technology), Shandong University of Traditional Chinese Medicine, Jinan, China.
Meng-Yue WuShandong Key Laboratory of Digital Traditional Chinese Medicine, Institute of Pharmacy (Institute of TCM Health Industrial Technology), Shandong University of Traditional Chinese Medicine, Jinan, China.
Kun DongShandong Key Laboratory of Digital Traditional Chinese Medicine, Institute of Pharmacy (Institute of TCM Health Industrial Technology), Shandong University of Traditional Chinese Medicine, Jinan, China.
Xiao-Yan LiShandong Key Laboratory of Digital Traditional Chinese Medicine, Institute of Pharmacy (Institute of TCM Health Industrial Technology), Shandong University of Traditional Chinese Medicine, Jinan, China.
Peng GaoShandong Key Laboratory of Digital Traditional Chinese Medicine, Institute of Pharmacy (Institute of TCM Health Industrial Technology), Shandong University of Traditional Chinese Medicine, Jinan, China.
Zhi-Hui JiangShandong Key Laboratory of Digital Traditional Chinese Medicine, Institute of Pharmacy (Institute of TCM Health Industrial Technology), Shandong University of Traditional Chinese Medicine, Jinan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical safety and therapeutic performance of Traditional Chinese Medicine (TCM) are closely tied to its quality. However, with the rapid expansion of the TCM industry, conventional quality control approaches based on empirical observations and single-metabolite quantification have become increasingly inadequate for addressing the complex and variable requirements of quality assessment. In recent years, artificial intelligence (AI)-with strong capabilities in data processing and pattern recognition-has emerged as a promising tool for establishing predictive models to efficiently handle heterogeneous, multi-source datasets (such as spectra, chromatograms, images, and textual information). This enables intelligent prediction of quality indicators and anomaly detection, and offering novel strategies for modernizing TCM quality control. This review provides a comprehensive synthesis of commonly applied machine learning and deep learning algorithms, systematically outlining recent advances in AI-enabled sensing applications such as image recognition, odor analysis, authenticity verification, origin tracing, quality grading, and storage-age determination. It further emphasizes the integration of AI with multi-omics and bioinformatics approaches for efficacy-oriented evaluation and safety assessment, including identification of Q-markers, elucidation of pharmacodynamic mechanisms, and predictive modeling of both endogenous and exogenous toxic metabolites. It also identifies key challenges and technical bottlenecks, and outlines priorities for building scalable, regulation-aware, data-driven quality-control systems that support the sustainable, high-quality development of the TCM industry.

Indexed as

artificial intelligencebioinformaticsmechanismmulti-omics technologiesquality controltraditional Chinese Medicine

Identifiers

PMID41181603
PMCPMC12575287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.